News
-
Risk Vs Benefits of Aspirin Revealed
Daily aspirin takers can get more benefit than harm, a group of independent experts at ..
13 Apr 2016
-
BromSite approved for postoperative inflammation treatment
The United States Food and Drug Administration (USFDA) has approved BromSite ..
12 Apr 2016
-
Liraglutide may help obese diabetics
Injectable Liraglutide along with exercise and dietary modifications can likely lead to ..
11 Apr 2016
-
Antioxidants can be helpful for elderly melanoma patients
Taking anti-oxidants can likely be to an effective treatment for elderly melanoma ..
08 Apr 2016
-
Certain DPP-4 inhibitors linked with heart failure risk
Anti-diabetic drugs such as Saxagliptin and Alogliptin may increase the risk of heart ..
07 Apr 2016
-
ADHD drugs may be adverse to bones
ADHD individuals who are on stimulants such as Adderall and Methylphenidate (Ritalin) ..
06 Apr 2016
-
Suntan can block vitamin D synthesis
Suntan can block harmful UV rays but significantly blocks vitamin D synthesis in the ..
05 Apr 2016
-
Maternal use of migraine drugs may affect babies
Certain anti-migraine drugs that are commonly prescribed and considered as safe in ..
04 Apr 2016
-
Pioglitazone linked with higher risk of bladder caner
Nothing new, the news that linked Pioglitazone use with increased risk of bladder cancer ..
01 Apr 2016
-
USFDA approved Anthrasil
The United States Food and Drug Administration (USFDA) approved Anthrasil (Anthrax ..
30 Mar 2015
-
Cholbam approved for bile acid disorders
The United States Food and Drug Administration approved Cholbam capsules (Cholic ..
23 Mar 2015
-
Cresemba approved by USFDA: Astellas Pharma
The United States Food and Drug Administration has approved Isavuconazonium sulfate ..
16 Mar 2015
-
USFDA approved first biosimiliar Zarxio
The United States Food and Drug Administration (USFDA) has approved Zarxio ..
09 Mar 2015
-
Farydak approved for multiple myeloma treatment
Farydak, Multiple myeloma, HDAC, Dexamethasone, Bortezomib..
02 Mar 2015
-
Banzel approved as an adjunctive therapy for LGS-associated seizures
The United States Food and Drug Administration (USFDA) has approved Banzel ..
23 Feb 2015
-
Tecfidera approved for MS in India
The Drug Controller General of India (DGCI) has approved the first oral drug Tecfidera ..
16 Feb 2015
-
Ibrance approved for metastatic breast cancer
The United States Food and Drug Administration (USFDA) approved Ibrance ..
09 Feb 2015
-
Triferic approved for iron replacement therapy
The United States Food and Drug Administration (USFDA) approved Triferic as an iron ..
02 Feb 2015
-
Top Indian Pharmas give in to foreign acquisition
Abbott Laboratories acquisition of Piramal Healthcare last week has now made the top three Indian Pharmas, a part of MNCs...
25 May 2010
-
Several CGHS hosiptals supply spurious drugs
In a startling disclosure, the Central Bureau of Investigations (CBI) found out that several Central Government Health Scheme (CGHS) dispensaries..
21 May 2010
-
Proposed NCHER to include Medicine & Law Education
The President has nodded approval for the dissolution of the Indian Medical Council...
21 May 2010
-
Venus to launch painkiller injection
Venus remedies has been granted patent rights in India for its new drug once a day Aceclofenac painkiller injection...
20 May 2010
-
Piramal Healthcare fourth quater net profit rises by 34%
Piramal Healthcare has reported its fourth quarter and full year results for the financial year 2010...
11 May 2010
-
Cipla launches cheaper version of German Cancer drug- Nexavar
Cipla has launched Soranib which is a cheaper copycat version of the cancer drug Nexavar by German company- Bayer...
09 Apr 2010
-
Govt may make to embossing batch number & expiry dates on tablets compulsary.
Recirculation of expired drugs is on the rise, and with the absense of law in place to curb it, Govt..
09 Apr 2010
-
Pfizer .Ltd has reported its first quater net profit and revenue
Pfizer had posted a net profit of Rs. 42.45 crores or Rs. 14.23 per share. In the first quater of..
29 Mar 2010
-
Cipla's I- Pill Acquired by Piramal Healthcare
Piramal Healthcare has secured the rights for emergency contraceptive drug I- Pill by Cipla's for Rs 950 million. ..
23 Mar 2010
FOLLOW US:
